Cucurbitacin B and cucurbitacin I suppress adipocyte differentiation through inhibition of STAT3 signaling. 2014

Cho-Rong Seo, and Dong Kwon Yang, and No-Joon Song, and Ui Jeong Yun, and A-Ryeong Gwon, and Dong-Gyu Jo, and Jae Youl Cho, and Keejung Yoon, and Jee-Yin Ahn, and Chu Won Nho, and Woo Jin Park, and Seung Yul Yang, and Kye Won Park
Department of Food Science and Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.

Cucurbitacin B, a member of the cucurbitaceae family, can act as a STAT3 signaling inhibitor to regulate the growth of hepatocellular carcinoma. STAT3 signaling has been shown to inhibit adipocyte differentiation through C/EBPα and PPARγ. Based on these studies, we hypothesized that cucurbitacin B would prevent PPARγ mediated adipocyte differentiation through STAT3 signaling. To test this hypothesis, mesenchymal C3H10T1/2 and 3T3-L1 preadipocyte cells were treated with a sub-cytotoxic concentration of cucurbitacin B. Cucurbitacin B treatment inhibits lipid accumulation and expression of adipocyte markers including PPARγ and its target genes in a dose-dependent manner. Cucurbitacin B treatment impairs STAT3 signaling as manifested by reduced phosphorylation of STAT3 and suppression of STAT3 target gene expression in preadipocytes. The anti-adipogenic effects of cucurbitacin B are significantly blunted in cells with STAT3 silenced by introducing small interfering RNA. Finally, our data show that cucurbitacin I, another cucurbitacin family member, also inhibits adipocyte differentiation by suppressing STAT3 signaling. Together, our data suggest the possibility of utilizing cucurbitacins as a new strategy to treat metabolic diseases and implicate STAT3 as a new target for the development of functional foods and drugs.

UI MeSH Term Description Entries
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D017667 Adipocytes Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals. Fat Cells,Lipocytes,Adipocyte,Cell, Fat,Cells, Fat,Fat Cell,Lipocyte
D050796 STAT3 Transcription Factor A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-6 family members. STAT3 is constitutively activated in a variety of TUMORS and is a major downstream transducer for the CYTOKINE RECEPTOR GP130. APRF Transcription Factor,Acute-Phase Response Factor,IL6-Response Factor,LIF-Response Factor,STAT3 Protein,STAT3a Transcription Factor,STAT3b Transcription Factor,Signal Transducer and Activator of Transcription 3,Stat3alpha Transcription Factor,Stat3beta Transcription Factor,Acute Phase Response Factor,IL6 Response Factor,LIF Response Factor,Response Factor, Acute-Phase,Transcription Factor, APRF,Transcription Factor, STAT3,Transcription Factor, STAT3a,Transcription Factor, STAT3b,Transcription Factor, Stat3alpha,Transcription Factor, Stat3beta
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D041721 3T3-L1 Cells A continuous cell line that is a substrain of SWISS 3T3 CELLS developed though clonal isolation. The mouse fibroblast cells undergo an adipose-like conversion as they move to a confluent and contact-inhibited state. 3T3-L1,3T3 L1 Cells,3T3-L1 Cell,Cell, 3T3-L1,Cells, 3T3-L1

Related Publications

Cho-Rong Seo, and Dong Kwon Yang, and No-Joon Song, and Ui Jeong Yun, and A-Ryeong Gwon, and Dong-Gyu Jo, and Jae Youl Cho, and Keejung Yoon, and Jee-Yin Ahn, and Chu Won Nho, and Woo Jin Park, and Seung Yul Yang, and Kye Won Park
June 2007, Molecular and cellular biology,
Cho-Rong Seo, and Dong Kwon Yang, and No-Joon Song, and Ui Jeong Yun, and A-Ryeong Gwon, and Dong-Gyu Jo, and Jae Youl Cho, and Keejung Yoon, and Jee-Yin Ahn, and Chu Won Nho, and Woo Jin Park, and Seung Yul Yang, and Kye Won Park
November 2023, Cellular and molecular biology (Noisy-le-Grand, France),
Cho-Rong Seo, and Dong Kwon Yang, and No-Joon Song, and Ui Jeong Yun, and A-Ryeong Gwon, and Dong-Gyu Jo, and Jae Youl Cho, and Keejung Yoon, and Jee-Yin Ahn, and Chu Won Nho, and Woo Jin Park, and Seung Yul Yang, and Kye Won Park
January 2024, The American journal of Chinese medicine,
Cho-Rong Seo, and Dong Kwon Yang, and No-Joon Song, and Ui Jeong Yun, and A-Ryeong Gwon, and Dong-Gyu Jo, and Jae Youl Cho, and Keejung Yoon, and Jee-Yin Ahn, and Chu Won Nho, and Woo Jin Park, and Seung Yul Yang, and Kye Won Park
February 2016, Molecular and cellular biochemistry,
Cho-Rong Seo, and Dong Kwon Yang, and No-Joon Song, and Ui Jeong Yun, and A-Ryeong Gwon, and Dong-Gyu Jo, and Jae Youl Cho, and Keejung Yoon, and Jee-Yin Ahn, and Chu Won Nho, and Woo Jin Park, and Seung Yul Yang, and Kye Won Park
October 2016, Experimental and therapeutic medicine,
Cho-Rong Seo, and Dong Kwon Yang, and No-Joon Song, and Ui Jeong Yun, and A-Ryeong Gwon, and Dong-Gyu Jo, and Jae Youl Cho, and Keejung Yoon, and Jee-Yin Ahn, and Chu Won Nho, and Woo Jin Park, and Seung Yul Yang, and Kye Won Park
June 2016, Cell death & disease,
Cho-Rong Seo, and Dong Kwon Yang, and No-Joon Song, and Ui Jeong Yun, and A-Ryeong Gwon, and Dong-Gyu Jo, and Jae Youl Cho, and Keejung Yoon, and Jee-Yin Ahn, and Chu Won Nho, and Woo Jin Park, and Seung Yul Yang, and Kye Won Park
January 2021, Acta endocrinologica (Bucharest, Romania : 2005),
Cho-Rong Seo, and Dong Kwon Yang, and No-Joon Song, and Ui Jeong Yun, and A-Ryeong Gwon, and Dong-Gyu Jo, and Jae Youl Cho, and Keejung Yoon, and Jee-Yin Ahn, and Chu Won Nho, and Woo Jin Park, and Seung Yul Yang, and Kye Won Park
March 2018, Acta pharmacologica Sinica,
Cho-Rong Seo, and Dong Kwon Yang, and No-Joon Song, and Ui Jeong Yun, and A-Ryeong Gwon, and Dong-Gyu Jo, and Jae Youl Cho, and Keejung Yoon, and Jee-Yin Ahn, and Chu Won Nho, and Woo Jin Park, and Seung Yul Yang, and Kye Won Park
January 2013, Cancer letters,
Cho-Rong Seo, and Dong Kwon Yang, and No-Joon Song, and Ui Jeong Yun, and A-Ryeong Gwon, and Dong-Gyu Jo, and Jae Youl Cho, and Keejung Yoon, and Jee-Yin Ahn, and Chu Won Nho, and Woo Jin Park, and Seung Yul Yang, and Kye Won Park
January 2017, Journal of cellular biochemistry,
Copied contents to your clipboard!